FDA NDC Directory · JSON-LD · Markdown

Levothyroxine Sodium

NDC 0904-6951 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerMajor Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA209713
Dosage form / routeTABLET · ORAL
Active ingredientsLEVOTHYROXINE SODIUM (.075 mg/1)
Marketing started20190320
Package count1

External sources

Source: openFDA. Public-domain (CC0).